Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GemOx + Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer
NCT00425841Phase 2Completed
- Sponsor
- Technical University of Munich
- Start
- May 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, oxaliplatin in pancreatic cancer (PC), sponsored by Technical University of Munich. Started May 2006; status: completed.
02
Drugs
gemcitabineoxaliplatin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00425841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425841.